Cancer-on-a-chip Systems at the Frontier of Nanomedicine

Yu Shrike Zhang,Yi-Nan Zhang,Weijia Zhang

DOI: https://doi.org/10.1016/j.drudis.2017.03.011

IF: 8.369

2017-01-01

Drug Discovery Today

Abstract:•Nanomedicine promotes drug efficacy through enhanced delivery mechanisms.•The translation of nanomedicine is slow with current cell culture and preclinical models.•Organ-on-a-chip platforms potentially better replicate the biology and physiology of the human system.•Cancer-on-a-chip platforms have potentials to use as alternatives for effective evaluation of nanomedicine.